Eletroanálise aplicada a ensaios de compatibilidade e estabilidade de fármacos
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Tipo de documento: | Tese |
Idioma: | por |
Título da fonte: | Repositório Institucional da UFG |
dARK ID: | ark:/38995/0013000003vvv |
Texto Completo: | http://repositorio.bc.ufg.br/tede/handle/tede/10852 |
Resumo: | Introduction: The pharmaceutical industry faces a major challenge to improve the solubility of some active ingredients. Carvedilol (CRV) is the drug of therapeutic choice in cardiovascular diseases. CRV presents low water solubility and low bioavaliability. Several researches were performed in order to increase the oral bioavailability, where selfemulsifying appeared as viable alternatives. Objective: The objective of this work was to evaluate interactions between CRV and its excipients, detecting the oxidative potential of these substances, thus, providing predictive data for the oxidation that may affect the stability and bioavailability of the drug system. Methodology: In the carbon pastes preparation were used 70 mg (graphite) and 30 mg (oil). Six excipients, oleic acid, canola, capmul, safflower, sesame and Plurol isoestearique. The following proportions were used in the making of the paste: 30:0, 20:10, 15:15, 10:20 and 0:30 of liquid excipient (sample): mineral oil (mg:mg) and 1.5:68.5, 3:67 and 7:63 of solid excipient (sample): graphite (mg:mg). CRV was incorporated in the oil moiety for solubilization and after used in solidstate analysis in the carbon paste. The techniques used were cyclic voltammetry, differential pulse voltammetry and electrochemical impedance spectroscopy. Results and Discussions: The Isostearique Plurol® was found to be electro-active in the studied potential, however, this oil oxidizes in different potentials from CRV. The results show that Isostearique Plurol®, liquid excipient, isoestearique acid and the solid excipient presented the greatest variations of anodic potential and were considered the best excipients for the CRV formulation. CRV presented higher stability at room temperature (25 ºC), whereas, it presented higher stability at 50 ºC when mixed with 7% estearique acid. Conclusions: Evidences of incompatibility were not found, relative to the increase of oxidation vulnerability, when in the presence of these excipients. The employment of electroanalysis for CRV compatibility studies show promising viability. |
id |
UFG-2_e03a3a13d0b50b94775981808dbb4593 |
---|---|
oai_identifier_str |
oai:repositorio.bc.ufg.br:tede/10852 |
network_acronym_str |
UFG-2 |
network_name_str |
Repositório Institucional da UFG |
repository_id_str |
|
spelling |
Gil, Eric de Souzahttp://lattes.cnpq.br/3218622824233303Garcia, Luane Ferreirahttp://lattes.cnpq.br/6624146379323596Garcia, Luane FerreiraLeite, Karla Carneiro de SiqueiraAlecrim, Morgana FernandesMarreto, Ricardo NevesOliveira, Thiago Levi Silvahttp://lattes.cnpq.br/2242548114202074Carvalho, Murilo Ferreira de2020-10-09T13:10:52Z2020-10-09T13:10:52Z2020-08-31Carvalho, M. F. Eletroanálise aplicada a ensaios de compatibilidade e estabilidade de fármacos. 2020. 43 f. Tese (Doutorado em Ciências Farmacêuticas) - Universidade Federal de Goiás, Goiânia, 2020.http://repositorio.bc.ufg.br/tede/handle/tede/10852ark:/38995/0013000003vvvIntroduction: The pharmaceutical industry faces a major challenge to improve the solubility of some active ingredients. Carvedilol (CRV) is the drug of therapeutic choice in cardiovascular diseases. CRV presents low water solubility and low bioavaliability. Several researches were performed in order to increase the oral bioavailability, where selfemulsifying appeared as viable alternatives. Objective: The objective of this work was to evaluate interactions between CRV and its excipients, detecting the oxidative potential of these substances, thus, providing predictive data for the oxidation that may affect the stability and bioavailability of the drug system. Methodology: In the carbon pastes preparation were used 70 mg (graphite) and 30 mg (oil). Six excipients, oleic acid, canola, capmul, safflower, sesame and Plurol isoestearique. The following proportions were used in the making of the paste: 30:0, 20:10, 15:15, 10:20 and 0:30 of liquid excipient (sample): mineral oil (mg:mg) and 1.5:68.5, 3:67 and 7:63 of solid excipient (sample): graphite (mg:mg). CRV was incorporated in the oil moiety for solubilization and after used in solidstate analysis in the carbon paste. The techniques used were cyclic voltammetry, differential pulse voltammetry and electrochemical impedance spectroscopy. Results and Discussions: The Isostearique Plurol® was found to be electro-active in the studied potential, however, this oil oxidizes in different potentials from CRV. The results show that Isostearique Plurol®, liquid excipient, isoestearique acid and the solid excipient presented the greatest variations of anodic potential and were considered the best excipients for the CRV formulation. CRV presented higher stability at room temperature (25 ºC), whereas, it presented higher stability at 50 ºC when mixed with 7% estearique acid. Conclusions: Evidences of incompatibility were not found, relative to the increase of oxidation vulnerability, when in the presence of these excipients. The employment of electroanalysis for CRV compatibility studies show promising viability.Introdução: A indústria farmacêutica enfrenta um grande desafio no sentido de melhorar a solubilidade de alguns insumos ativos. O Carvedilol (CRV) é um dos fármacos de escolha para o tratamento das doenças cardiovasculares, que apresenta baixa solubilidade em água e baixa biodisponibilidade, motivando a realização de pesquisas para melhorar a biodisponibilidade por via oral, sendo os sistemas auto-emulsificantes uma alternativa promissora. Objetivo: O objetivo deste trabalho foi avaliar as interações entre o CRV e os excipientes, detectando o potencial oxidante dessas substâncias e fornecendo dados preditivos da estabilidade do sistema e biodisponibilidade do fármaco. Metodologia: No preparo das pastas foram utilizados 70 mg (grafite) e 30 mg (óleo). Os excipientes, ácido oleico, canola, capmul, cártamo, gergelim e plurol isostearique, foram utilizados no preparo das pastas, na proporção de 30:0, 20:10, 15:15, 10:20 e 0:30 deexcipiente líquido (amostra): óleo mineral (mg:mg) ou 1,5:68,5, 3:67 e 7:63 de excipiente sólido (amostra): grafite (mg:mg). O CRV foi incorporado na porção oleosa para solubilização e após o preparo da pasta de carbono foi utilizado nas análises em estado sólido. As técnicas utilizadas no estudo foram voltametria cíclica, de pulso diferencial e espectroscopia de impedância eletroquímica. Resultados e discussões: O Plurol® isostearique foi eletroativo na faixa de potencial estudada, porém, esse óleo se oxida em potenciais diferentes do CRV, não inviabilizando a análise. Os resultados mostraram que o Plurol® isostearique, excipiente líquido, e ácido esteárico, excipiente sólido, apresentaram as maiores variações de potencial de pico anódico e foram considerados os melhores excipientes para a formulação de CRV. O fármaco analisado apresentou maior estabilidade à temperatura ambiente e a 50 °C quando misturada com ácido esteárico a 7%. Conclusões: Nos ensaios realizados não se observou evidências de incompatibilidade, relativa ao aumento da vulnerabilidade à oxidação, quando na presença de todos estes excipientes. Estudos em longo prazo são uma possibilidade real para avaliar o emprego da eletroanálise em estudos de compatibilidade do CRV no desenvolvimento de formulações.Submitted by Valéria Martins (valeriamartins@ufg.br) on 2020-10-08T14:04:52Z No. of bitstreams: 2 license_rdf: 805 bytes, checksum: 4460e5956bc1d1639be9ae6146a50347 (MD5) Tese - Murilo Ferreira de Carvalho - 2020.pdf: 10209755 bytes, checksum: ea03260bad2b8e2f085a56aa1bc1bdb9 (MD5)Rejected by Luciana Ferreira (lucgeral@gmail.com), reason: Observe como digitou as palavras-chave (A primeira letra da primeira palavra deve ser sempre maiúscula, caso seja uma expressão, também, somente a primeira letra da primeira palavra fica em maiúsculo, a não ser que seja nome próprio): ERRADO Espectroscopia de Impedância Eletroquímica Bloqueador de Receptores Adrenérgicos Tecnologia Farmacêutica Electrochemical Impedance Spectroscopy Adrenergic Receptor Blocker Pharmaceutical Technology CERTO Espectroscopia de impedância eletroquímica Bloqueador de receptores adrenérgicos Tecnologia farmacêutica Electrochemical impedance spectroscopy Adrenergic receptor blocker Pharmaceutical technology on 2020-10-08T15:12:33Z (GMT)Submitted by Valéria Martins (valeriamartins@ufg.br) on 2020-10-09T11:36:25Z No. of bitstreams: 2 license_rdf: 805 bytes, checksum: 4460e5956bc1d1639be9ae6146a50347 (MD5) Tese - Murilo Ferreira de Carvalho - 2020.pdf: 10209755 bytes, checksum: ea03260bad2b8e2f085a56aa1bc1bdb9 (MD5)Approved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2020-10-09T13:10:52Z (GMT) No. of bitstreams: 2 license_rdf: 805 bytes, checksum: 4460e5956bc1d1639be9ae6146a50347 (MD5) Tese - Murilo Ferreira de Carvalho - 2020.pdf: 10209755 bytes, checksum: ea03260bad2b8e2f085a56aa1bc1bdb9 (MD5)Made available in DSpace on 2020-10-09T13:10:52Z (GMT). No. of bitstreams: 2 license_rdf: 805 bytes, checksum: 4460e5956bc1d1639be9ae6146a50347 (MD5) Tese - Murilo Ferreira de Carvalho - 2020.pdf: 10209755 bytes, checksum: ea03260bad2b8e2f085a56aa1bc1bdb9 (MD5) Previous issue date: 2020-08-31porUniversidade Federal de GoiásPrograma de Pós-graduação em Ciências Farmacêuticas (FF)UFGBrasilFaculdade de Farmácia - FF (RG)Attribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessVoltametriaEspectroscopia de impedância eletroquímicaBloqueador de receptores adrenérgicosTecnologia farmacêuticaFormulaçãoExcipientesVoltammetryElectrochemical impedance spectroscopyAdrenergic receptor blockerPharmaceutical technologyFormulationExcipientsCIENCIAS BIOLOGICAS::FARMACOLOGIA::FARMACOLOGIA GERALEletroanálise aplicada a ensaios de compatibilidade e estabilidade de fármacosElectroanalysis applied to compatibility and stability assays of medicinesinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesis2650050050022524reponame:Repositório Institucional da UFGinstname:Universidade Federal de Goiás (UFG)instacron:UFGLICENSElicense.txtlicense.txttext/plain; charset=utf-81748http://repositorio.bc.ufg.br/tede/bitstreams/04c41eef-c63f-4d3a-966c-3bd488b2fa30/download8a4605be74aa9ea9d79846c1fba20a33MD54CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8805http://repositorio.bc.ufg.br/tede/bitstreams/c895f086-5860-4eb4-9817-feb2d95296aa/download4460e5956bc1d1639be9ae6146a50347MD52ORIGINALTese - Murilo Ferreira de Carvalho - 2020.pdfTese - Murilo Ferreira de Carvalho - 2020.pdfapplication/pdf10209755http://repositorio.bc.ufg.br/tede/bitstreams/6431b4ff-3037-43bb-9524-1b4137b004f0/downloadea03260bad2b8e2f085a56aa1bc1bdb9MD53tede/108522020-10-09 10:10:53.354http://creativecommons.org/licenses/by-nc-nd/4.0/Attribution-NonCommercial-NoDerivatives 4.0 Internationalopen.accessoai:repositorio.bc.ufg.br:tede/10852http://repositorio.bc.ufg.br/tedeRepositório InstitucionalPUBhttp://repositorio.bc.ufg.br/oai/requesttasesdissertacoes.bc@ufg.bropendoar:2020-10-09T13:10:53Repositório Institucional da UFG - Universidade Federal de Goiás (UFG)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 |
dc.title.pt_BR.fl_str_mv |
Eletroanálise aplicada a ensaios de compatibilidade e estabilidade de fármacos |
dc.title.alternative.eng.fl_str_mv |
Electroanalysis applied to compatibility and stability assays of medicines |
title |
Eletroanálise aplicada a ensaios de compatibilidade e estabilidade de fármacos |
spellingShingle |
Eletroanálise aplicada a ensaios de compatibilidade e estabilidade de fármacos Carvalho, Murilo Ferreira de Voltametria Espectroscopia de impedância eletroquímica Bloqueador de receptores adrenérgicos Tecnologia farmacêutica Formulação Excipientes Voltammetry Electrochemical impedance spectroscopy Adrenergic receptor blocker Pharmaceutical technology Formulation Excipients CIENCIAS BIOLOGICAS::FARMACOLOGIA::FARMACOLOGIA GERAL |
title_short |
Eletroanálise aplicada a ensaios de compatibilidade e estabilidade de fármacos |
title_full |
Eletroanálise aplicada a ensaios de compatibilidade e estabilidade de fármacos |
title_fullStr |
Eletroanálise aplicada a ensaios de compatibilidade e estabilidade de fármacos |
title_full_unstemmed |
Eletroanálise aplicada a ensaios de compatibilidade e estabilidade de fármacos |
title_sort |
Eletroanálise aplicada a ensaios de compatibilidade e estabilidade de fármacos |
author |
Carvalho, Murilo Ferreira de |
author_facet |
Carvalho, Murilo Ferreira de |
author_role |
author |
dc.contributor.advisor1.fl_str_mv |
Gil, Eric de Souza |
dc.contributor.advisor1Lattes.fl_str_mv |
http://lattes.cnpq.br/3218622824233303 |
dc.contributor.advisor-co1.fl_str_mv |
Garcia, Luane Ferreira |
dc.contributor.advisor-co1Lattes.fl_str_mv |
http://lattes.cnpq.br/6624146379323596 |
dc.contributor.referee1.fl_str_mv |
Garcia, Luane Ferreira |
dc.contributor.referee2.fl_str_mv |
Leite, Karla Carneiro de Siqueira |
dc.contributor.referee3.fl_str_mv |
Alecrim, Morgana Fernandes |
dc.contributor.referee4.fl_str_mv |
Marreto, Ricardo Neves |
dc.contributor.referee5.fl_str_mv |
Oliveira, Thiago Levi Silva |
dc.contributor.authorLattes.fl_str_mv |
http://lattes.cnpq.br/2242548114202074 |
dc.contributor.author.fl_str_mv |
Carvalho, Murilo Ferreira de |
contributor_str_mv |
Gil, Eric de Souza Garcia, Luane Ferreira Garcia, Luane Ferreira Leite, Karla Carneiro de Siqueira Alecrim, Morgana Fernandes Marreto, Ricardo Neves Oliveira, Thiago Levi Silva |
dc.subject.por.fl_str_mv |
Voltametria Espectroscopia de impedância eletroquímica Bloqueador de receptores adrenérgicos Tecnologia farmacêutica Formulação Excipientes |
topic |
Voltametria Espectroscopia de impedância eletroquímica Bloqueador de receptores adrenérgicos Tecnologia farmacêutica Formulação Excipientes Voltammetry Electrochemical impedance spectroscopy Adrenergic receptor blocker Pharmaceutical technology Formulation Excipients CIENCIAS BIOLOGICAS::FARMACOLOGIA::FARMACOLOGIA GERAL |
dc.subject.eng.fl_str_mv |
Voltammetry Electrochemical impedance spectroscopy Adrenergic receptor blocker Pharmaceutical technology Formulation Excipients |
dc.subject.cnpq.fl_str_mv |
CIENCIAS BIOLOGICAS::FARMACOLOGIA::FARMACOLOGIA GERAL |
description |
Introduction: The pharmaceutical industry faces a major challenge to improve the solubility of some active ingredients. Carvedilol (CRV) is the drug of therapeutic choice in cardiovascular diseases. CRV presents low water solubility and low bioavaliability. Several researches were performed in order to increase the oral bioavailability, where selfemulsifying appeared as viable alternatives. Objective: The objective of this work was to evaluate interactions between CRV and its excipients, detecting the oxidative potential of these substances, thus, providing predictive data for the oxidation that may affect the stability and bioavailability of the drug system. Methodology: In the carbon pastes preparation were used 70 mg (graphite) and 30 mg (oil). Six excipients, oleic acid, canola, capmul, safflower, sesame and Plurol isoestearique. The following proportions were used in the making of the paste: 30:0, 20:10, 15:15, 10:20 and 0:30 of liquid excipient (sample): mineral oil (mg:mg) and 1.5:68.5, 3:67 and 7:63 of solid excipient (sample): graphite (mg:mg). CRV was incorporated in the oil moiety for solubilization and after used in solidstate analysis in the carbon paste. The techniques used were cyclic voltammetry, differential pulse voltammetry and electrochemical impedance spectroscopy. Results and Discussions: The Isostearique Plurol® was found to be electro-active in the studied potential, however, this oil oxidizes in different potentials from CRV. The results show that Isostearique Plurol®, liquid excipient, isoestearique acid and the solid excipient presented the greatest variations of anodic potential and were considered the best excipients for the CRV formulation. CRV presented higher stability at room temperature (25 ºC), whereas, it presented higher stability at 50 ºC when mixed with 7% estearique acid. Conclusions: Evidences of incompatibility were not found, relative to the increase of oxidation vulnerability, when in the presence of these excipients. The employment of electroanalysis for CRV compatibility studies show promising viability. |
publishDate |
2020 |
dc.date.accessioned.fl_str_mv |
2020-10-09T13:10:52Z |
dc.date.available.fl_str_mv |
2020-10-09T13:10:52Z |
dc.date.issued.fl_str_mv |
2020-08-31 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/doctoralThesis |
format |
doctoralThesis |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
Carvalho, M. F. Eletroanálise aplicada a ensaios de compatibilidade e estabilidade de fármacos. 2020. 43 f. Tese (Doutorado em Ciências Farmacêuticas) - Universidade Federal de Goiás, Goiânia, 2020. |
dc.identifier.uri.fl_str_mv |
http://repositorio.bc.ufg.br/tede/handle/tede/10852 |
dc.identifier.dark.fl_str_mv |
ark:/38995/0013000003vvv |
identifier_str_mv |
Carvalho, M. F. Eletroanálise aplicada a ensaios de compatibilidade e estabilidade de fármacos. 2020. 43 f. Tese (Doutorado em Ciências Farmacêuticas) - Universidade Federal de Goiás, Goiânia, 2020. ark:/38995/0013000003vvv |
url |
http://repositorio.bc.ufg.br/tede/handle/tede/10852 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.program.fl_str_mv |
26 |
dc.relation.confidence.fl_str_mv |
500 500 500 |
dc.relation.department.fl_str_mv |
22 |
dc.relation.cnpq.fl_str_mv |
524 |
dc.rights.driver.fl_str_mv |
Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Universidade Federal de Goiás |
dc.publisher.program.fl_str_mv |
Programa de Pós-graduação em Ciências Farmacêuticas (FF) |
dc.publisher.initials.fl_str_mv |
UFG |
dc.publisher.country.fl_str_mv |
Brasil |
dc.publisher.department.fl_str_mv |
Faculdade de Farmácia - FF (RG) |
publisher.none.fl_str_mv |
Universidade Federal de Goiás |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFG instname:Universidade Federal de Goiás (UFG) instacron:UFG |
instname_str |
Universidade Federal de Goiás (UFG) |
instacron_str |
UFG |
institution |
UFG |
reponame_str |
Repositório Institucional da UFG |
collection |
Repositório Institucional da UFG |
bitstream.url.fl_str_mv |
http://repositorio.bc.ufg.br/tede/bitstreams/04c41eef-c63f-4d3a-966c-3bd488b2fa30/download http://repositorio.bc.ufg.br/tede/bitstreams/c895f086-5860-4eb4-9817-feb2d95296aa/download http://repositorio.bc.ufg.br/tede/bitstreams/6431b4ff-3037-43bb-9524-1b4137b004f0/download |
bitstream.checksum.fl_str_mv |
8a4605be74aa9ea9d79846c1fba20a33 4460e5956bc1d1639be9ae6146a50347 ea03260bad2b8e2f085a56aa1bc1bdb9 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFG - Universidade Federal de Goiás (UFG) |
repository.mail.fl_str_mv |
tasesdissertacoes.bc@ufg.br |
_version_ |
1815172550266716160 |